Article
A genetic locus in 7p12.2 associated with treatment resistant schizophrenia.
Schizophrenia research - 1 Nov 2014
Li Jiang, Meltzer Herbert Y
Abstract excerpt
Approximately 30% of patients with schizophrenia are treatment resistant (TRS), i.e. have persistent psychotic symptoms despite adequate trials of at least two antipsychotic drugs (APDs). Most TRS patients are candidates for clozapine treatment which is underutilized because of its side effects and difficulty in identifying TRS. We conducted a genome-wide association study (GWAS) of 79 TRS and 95 non-treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
